Background
Methods
Design
Participants
Intervention
Lesson | Content |
---|---|
1
| Cannabis: What is it? |
Short-term effects of cannabis | |
Reasons people use cannabis | |
Cannabis and the law | |
Risk and protective factors for drug use | |
Conservative norms: prevalence of cannabis use | |
Mental health and cannabis | |
2
| Critical analysis of drug-related internet and media resources |
Classifying drugs: hallucinogens, stimulants and depressants | |
Psychostimulants: What are they? | |
Common names and properties of psychostimulant drugs | |
Short-term effects of psychostimulants | |
Conservative norms: Prevalence of psychostimulant use | |
The multifaceted nature of the effects of drug use on people’s lives | |
3
| Definitions, examples and effects of poly-drug use |
Classifying drugs | |
The indirect negative consequences of drug use | |
Problem solving and decision making skills in relation to drugs | |
Identifying drug related risk and minimising drug related harms | |
4
| Communication skills |
Avenues for seeking help and barriers to accessing services | |
What to do in a drug related emergency | |
Calling 000, the emergency number | |
Identifying communication styles, including assertiveness | |
5
| Long-term effects of drugs |
Drug withdrawal | |
Harm-minimisation strategies | |
Learning about resilience | |
Attitudes to drug use | |
Prevalence of psychostimulants and cannabis use | |
CPR and first aid | |
6
| Drugs and driving |
Drugs and the law | |
Problem solving skills | |
Legalisation, decriminalisation and criminalization of drugs – the debate | |
The effects of drugs on life’s journey | |
The effects of drugs on others |
Measures
Baseline | Intervention | Immediate post-intervention | 5 month follow-up | 10 month follow-up | |
---|---|---|---|---|---|
Timing
| Term 2 | Term 2&3 | Term 2&3 | Term 4 | Term 2 |
March-April | April-June | June-August | October-November | March-June | |
2008 | 2008 | 2008 | 2008 | 2009 | |
Intervention group
| Survey 1 | Climate Schools Intervention | Survey 2 | Survey 3 | Survey 4 |
Control group
| Survey 1 | Survey 2 | Survey 3 | Survey 4 |
Demographics
Knowledge about cannabis and psychostimulants
Attitudes to cannabis and psychostimulant use
Cannabis and psychostimulant use
Intention to use drugs in the future
Program evaluation and implementation
Control group questionnaire
Statistical methods
Sample size calculations
Results
Sample
Baseline equivalence
Attrition and differential attrition analyses
Outcome variable | Single | Repeat |
df
|
df error
|
F
|
p
|
---|---|---|---|---|---|---|
Cannabis Knowledge | 8.58 | 8.78 | 1 | 1727 | 1.46 | p = 0.23 |
Psychostimulant Knowledge | 8.26 | 8.51 | 1 | 1721 | 2.16 | p = 0.14 |
Cannabis Attitudes | 9.64 | 8.24 | 1 | 1730 | 47.24 | p < 0.0001 |
Psychostimulant Attitudes | 10.20 | 8.91 | 1 | 1730 | 41.57 | p < 0.0001 |
Cannabis frequency of use (three months) | 0.47 | 0.12 | 1 | 1720 | 48.25 | p < 0.001 |
Meth/amphetamine frequency of use (12 months) | 0.22 | 0.07 | 1 | 1727 | 17.61 | p < 0.001 |
Ecstasy frequency of use (last 12 months) | 0.29 | 0.09 | 1 | 1727 | 29.8 | p < 0.001 |
Cannabis intention 12 months | 1.10 | 0.60 | 1 | 1729 | 44.61 | p < 0.001 |
Meth/amphetamine intention 12 months | 0.62 | 0.30 | 1 | 1727 | 38.20 | p < 0.001 |
Ecstasy intention 12 months | 0.71 | 0.38 | 1 | 1727 | 29.66 | p < 0.001 |
Single
|
Repeat
|
df
|
χ
2
|
p
| ||
Lifetime cannabis use | 0.22 | 0.10 | 1 | 33.58 | p < 0.0001 | |
Lifetime Methamphetamine use | 0.10 | 0.03 | 1 | 27.37 | p < 0.0001 | |
Lifetime ecstasy use | 0.12 | 0.05 | 1 | 32.2 | p < 0.0001 |
Intervention effects
Baseline | Post | Five month follow-up | 10-month follow-up | ||
---|---|---|---|---|---|
Cannabis Knowledge
a
|
Control
| 8.81 | 9.25 | 9.14 | 9.51 |
(8.63-8.98) | (9.04-9.46) | (8.87-9.41) | (9.24-9.78) | ||
(n = 826) | (n = 576) | (n = 448) | (n = 403) | ||
Intervention
| 8.69 | 10.76 | 10.42 | 10.39 | |
(8.52-8.86) | (10.58-10.94) | (10.22-10.62) | (10.17-10.61) | ||
(n = 902) | (n = 627) | (n = 612) | (n = 570) | ||
Psycho-stimulants knowledge
a
|
Control
| 8.49 | 9.08 | 8.89 | 9.34 |
(8.31-8.67) | (8.86-9.30) | (8.60-9.18) | (9.05-9.63) | ||
(n = 823) | (n = 577) | (n = 449) | (n = 403) | ||
Intervention
| 8.45 | 10.46 | 10.25 | 10.28 | |
(8.27-8.63) | (10.26-10.66) | (10.03-10.47) | (10.04-10.52) | ||
(n = 899) | (n = 627) | (n = 613) | (n = 569) | ||
Cannabis Attitude
b
|
Control
| 8.86 | 8.71 | 8.61 | 8.85 |
(8.62-9.10) | (8.46-8.96) | (8.32-8.90) | (8.54-9.16) | ||
(n = 826) | (n = 578) | (n = 445) | (n = 403) | ||
Intervention
| 8.13 | 8.04 | 8.30 | 7.95 | |
(7.93-8.33) | (7.80-8.28) | (8.05-8.55) | (7.70-8.20) | ||
(n = 905) | (n = 626) | (n = 612) | (n = 568) | ||
Psycho-stimulants Attitude
b
|
Control
| 9.36 | 9.55 | 9.34 | 9.68 |
(9.14-9.58) | (9.30-9.80) | (9.05-9.63) | (9.37-9.99) | ||
(n = 824) | (n = 577) | (n = 445) | (n = 403) | ||
Intervention
| 8.93 | 8.88 | 8.96 | 8.74 | |
(8.71-9.15) | (8.63-9.13) | (8.71-9.21) | (8.49-8.99) | ||
(n = 904) | (n = 626) | (n = 614) | (n = 568) |
Baseline | Post-intervention | Five month follow-up | 10 month follow-up | ||
---|---|---|---|---|---|
Proportion ever used cannabis
|
Control
| 0.15 | 0.16 | 0.16 | 0.20 |
(0.13-0.17) | (0.13-0.19) | (0.13-0.19) | (0.16-0.24) | ||
(n = 828) | (n = 580) | (n = 450) | (n = 403) | ||
Intervention
| 0.09 | 0.11 | 0.13 | 0.12 | |
(0.07-0.11) | (0.09-0.13) | (0.10-0.16) | (0.09-0.15) | ||
(n = 903) | (n = 627) | (n = 614) | (n = 570) | ||
Proportion ever used meth/amphetamine
|
Control
| 0.05 | 0.06 | 0.07 | 0.05 |
(0.04-0.06) | (0.04-0.08) | (0.05-0.09) | (0.03-0.07) | ||
(n = 827) | (n = 577) | (n =449) | (n = 403) | ||
Intervention
| 0.04 | 0.03 | 0.05 | 0.04 | |
(0.03-0.05) | (0.02-0.04) | (0.03-0.07) | (0.02-0.06) | ||
(n = 906) | (n = 627 | (n = 613) | (n = 570) | ||
Proportion ever used ecstasy
|
Control
| 0.07 | 0.09 | 0.09 | 0.07 |
(0.05-0.09) | (0.07-0.11) | (0.07-0.12) | (0.05-0.09) | ||
(n = 827) | (n = 580) | (n = 449) | (n = 403) | ||
Intervention
| 0.05 | 0.05 | 0.06 | 0.06 | |
(0.04-0.07) | (0.03-0.06) | (0.04-0.08) | (0.04-0.08) | ||
(n = 904) | (n = 627) | (n = 614) | (n = 569) |
Baseline | Post | Five month follow-up | 10 month follow-up | ||
---|---|---|---|---|---|
Frequency of cannabis use in last three months
a
|
Control
| 0.24 | 0.25 | 0.27 | 0.29 |
(0.18-0.30) | (0.17-0.33) | (0.19-0.35) | (0.19-0.39) | ||
(n = 823) | (n = 579) | (n = 447) | (n = 403) | ||
Intervention
| 0.12 | 0.15 | 0.22 | 0.16 | |
(0.08-0.16) | (0.09-0.21) | (0.14-0.30) | (0.10-0.22) | ||
(n = 898) | (n = 626) | (n = 614) | (n = 568) | ||
Frequency of meth/amphetamine use in last 12 months
b
|
Control
| 0.12 | 0.13 | 0.09 | 0.10 |
(0.04-0.12) | (0.02-0.10) | (0.07-0.15) | (0.07-0.15) | ||
(n = 824) | (n = 578) | (n = 449) | (n = 403) | ||
Intervention
| 0.08 | 0.06 | 0.11 | 0.09 | |
(0.04-0.12) | (0.02-0.10) | (0.07-0.15) | (0.05-0.13) | ||
(n = 904) | (n = 628) | (n = 614) | (n = 569) | ||
Frequency of ecstasy use in last 12 months
b
|
Control
| 0.15 | 0.18 | 0.16 | 0.12 |
(0.11-0.19) | (0.12-0.24) | (0.10-0.22) | (0.10-0.22) | ||
(n = 824) | (n = 578) | (n = 447) | (n = 403) | ||
Intervention
| 0.10 | 0.10 | 0.12 | 0.11 | |
(0.06-0.14) | (0.06-0.14) | (0.08-0.16) | (0.07-0.15) | ||
(n = 904) | (n = 628) | (n = 614) | (n = 569) |
Baseline | Post | Five month follow-up | 10 month follow-up | ||
---|---|---|---|---|---|
Intention to use cannabis in the next 12 months
|
Control
| 0.82 | 0.92 | 0.93 | 0.95 |
(0.74-0.90) | (0.80-1.04) | (0.79-1.07) | (0.81-1.09) | ||
(n = 827) | (n = 579) | (n = 448) | (n = 403) | ||
Intervention
| 0.56 | 0.62 | 0.72 | 0.61 | |
(0.48-0.64) | (0.54-0.70) | (0.62-0.82) | (0.51-0.71) | ||
(n = 903) | N = 627 | (n = 614) | (n = 570) | ||
Intention to use methamphetamine in the next 12 months
|
Control
| 0.41 | 0.52 | 0.45 | 0.49 |
(0.35-0.47) | (0.44-0.60) | (0.35-0.55) | (0.39-0.59) | ||
(n = 827) | (n = 577) | (n = 447) | (n = 403) | ||
Intervention
| 0.29 | 0.34 | 0.36 | 0.36 | |
(0.23-0.35) | (0.28-0.40) | (0.28-0.44) | (0.28-0.44) | ||
(n = 902) | (n = 625) | (n = 614) | (n = 569) | ||
Intention to use ecstasy in the next 12 months
|
Control
| 0.50 | 0.63 | 0.63 | 0.62 |
(0.44-0.56) | (0.53-0.73) | (0.53-0.73) | (0.50-0.74) | ||
(n = 823) | (n = 577) | (n = 445) | (n = 402) | ||
Intervention
| 0.39 | 0.40 | 0.49 | 0.46 | |
(0.33-0.45) | (0.32-0.48) | (0.40-0.56) | (0.38-0.54) | ||
(n = 905) | (n = 625) | (n = 614) | (n = 569) |